780 ALTA-002, a SIRPα-directed TLR9 agonist antibody conjugate activates myeloid cells and promotes anti-tumor immunity

• Min Li,
• Ons Harrabi,
• Amy Chen,
• Emma Sangalang,
• Danielle Fontaine,
• Jaume Pons,
• Janet Sim,
• Tracy Kuo,
• Hong Wan

Affiliations

Min Li

Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Ons Harrabi

1Tallac Therapeutics, Burlingame, CA, USA

Amy Chen

1Tallac Therapeutics, Burlingame, CA, USA

Emma Sangalang

1Tallac Therapeutics, Burlingame, CA, USA

Danielle Fontaine

1Tallac Therapeutics, Burlingame, CA, USA

Jaume Pons

3ALX Oncology, Inc., Burlingame, CA, USA

Janet Sim

1Tallac Therapeutics, Burlingame, CA, USA

Tracy Kuo

1Tallac Therapeutics, Burlingame, CA, USA

Hong Wan

1Tallac Therapeutics, Burlingame, CA, USA